A Blood Test May Help Predict Confusion after Surgery
Reports new study in Biological Psychiatry
Reports new study in Biological Psychiatry
Many people experience an extended period of confusion when they awake after surgery. This acute confusional state, called delirium, particularly affects older adults and poses an important clinical challenge as it can lead to greater postoperative complications and may extend hospitalization.
In an effort to identify a biological marker to help guide intervention, a new study in Biological Psychiatry reports that postoperative delirium is associated with signs of inflammation – specifically elevations in the inflammatory marker C-reactive protein (CRP) – in patients 70 years of age or older. The study, led by co-senior authors Towia Libermann and Edward Marcantonio, both of Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, supports previous reports of associations between CRP and delirium after surgery, and shows for the first time significant elevations of the blood-based marker before surgery.
“Our ability to pinpoint CRP levels as being significantly elevated before and after postoperative delirium onset establishes CRP as a risk marker, as well as a disease marker, for delirium,” said Sarinnapha Vasunilashorn, co-first author of the study, along with Simon Dillon, also of BIDMC.
Blood samples were drawn at four time points before and after surgery from relatively healthy older adults who were undergoing major elective surgery. When Dillon and colleagues used a global proteomics approach to compare all proteins in the blood from a subset of the patients, CRP emerged with the strongest association to postoperative delirium.
To validate the association, the researchers confirmed differences in CRP protein levels in the blood samples of cases (patients who developed postoperative delirium) and controls (patients who did not develop delirium). A discovery cohort of 39 matched case–control pairs revealed that cases had higher CRP levels before the surgery and two days after, when delirium peaks. In a replication cohort of 36 different matched pairs, cases had higher CRP levels immediately after surgery and two days later.
According to Vasunilashorn, the elevated preoperative CRP levels in patients who go on to develop delirium mean that CRP could be used as a risk predictor to stratify patients before surgery.
“This study is a step toward preventing postoperative delirium,” said John Krystal, Editor of Biological Psychiatry. “With information about delirium risk, doctors can take steps before, during, and after surgery to reduce that risk,” for example, by reducing inflammation in patients with higher levels of CRP.
The findings also provide insight into what causes delirium and what puts someone at risk. “[I]t suggests there are differences in the inflammatory response of patients who develop delirium even prior to the surgical insult,” said Vasunilashorn, “a finding that will lead to new, important lines of investigation.”
Notes for editors
The article is "Higher C-Reactive Protein Levels Predict Postoperative Delirium in Older Patients Undergoing Major Elective Surgery: A Longitudinal Nested Case-Control Study," by Simon T. Dillon, Sarinnapha M. Vasunilashorn, Long Ngo, Hasan H. Otu, Sharon K. Inouye, Richard N. Jones, David C. Alsop, George A. Kuchel, Eran D. Metzger, Steven E. Arnold, Edward R. Marcantonio, and Towia A. Libermann (doi: 10.1016/j.biopsych.2016.03.2098). It appears in Biological Psychiatry, volume 81, issue 2 (2017), published by Elsevier.
Copies of this paper are available to credentialed journalists upon request; please contact Rhiannon Bugno at +1 214 648 0880 or firstname.lastname@example.org. Journalists wishing to interview the authors may contact Sarinnapha Vasunilashorn, Ph.D., at email@example.com.
The authors’ affiliations, and disclosures of financial and conflicts of interests are available in the article.
John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine, Chief of Psychiatry at Yale-New Haven Hospital, and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.
About Biological Psychiatry
Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.
The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.
Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 140 Psychiatry titles and 11th out of 256 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2015 Impact Factor score for Biological Psychiatry is 11.212.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Editorial Office, Biological Psychiatry
+1 214 648 0880